HIV and Injecting Drugs 101 (PDF - 460 KB)
This document provides essential information on reducing the risk of HIV for individuals who inject drugs.
This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 (PDF - 609 KB) and Volume 2 (PDF - 1.3 MB) of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.
This document provides essential information on reducing the risk of HIV for individuals who inject drugs.
This toolkit discusses Medicaid payment strategies in Arizona, New York, Oregon, and Pennsylvania that are being used to improve the delivery of substance use disorder (SUD) treatment for patients insured through Medicaid.
This web page includes links to 16 different screening tools for substance use with the number of questions for each and categories based on population and use.
This report describes policy priorities for Medicaid/Children's Health Insurance Program (CHIP) that States could implement to improve services and care for adolescents and young adults with substance use disorders, with a focus on prevention and early intervention.
This FDA page provides an index of over 400 FDA approved drugs and their descriptions. Note that it does not include all FDA approved drugs, but shares other resources to find more information on drugs not included on the list.
This issue brief provides best practices from health insurance providers related to integrating behavioral health and primary care to improve health outcomes, including potential policy solutions and opportunities.
This publication describes approaches for integrating behavioral health (including mental health and substance use) care into primary care and how integrated practices can provide better services to meet mental health, substance use, and other medical needs.
This report aims to address the treatment opportunities for pregnant and postpartum (or parenting) women (PPW) with substance use disorder (SUD) by describing opportunities to integrate obstetricians and gynecologists (OB/GYN) and SUD care as well as barriers to integrated care delivery.
Based on 2022 and earlier NSDUH data, this report contains findings on a wide variety of key substance use and mental health indicators in the United States.